1. Home
  2. TLYS vs RLYB Comparison

TLYS vs RLYB Comparison

Compare TLYS & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tilly's Inc.

TLYS

Tilly's Inc.

HOLD

Current Price

$4.52

Market Cap

43.3M

ML Signal

HOLD

Logo Rallybio Corporation

RLYB

Rallybio Corporation

HOLD

Current Price

$13.89

Market Cap

43.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLYS
RLYB
Founded
1982
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.3M
43.9M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
TLYS
RLYB
Price
$4.52
$13.89
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
425.2K
60.9K
Earning Date
06-03-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
62.34
N/A
EPS
N/A
N/A
Revenue
N/A
$858,000.00
Revenue This Year
$4.66
N/A
Revenue Next Year
$1.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.00
52 Week Low
$0.57
$0.27
52 Week High
$5.54
$11.49

Technical Indicators

Market Signals
Indicator
TLYS
RLYB
Relative Strength Index (RSI) 55.97 89.64
Support Level $3.67 $0.54
Resistance Level $5.54 N/A
Average True Range (ATR) 0.34 0.43
MACD -0.14 0.36
Stochastic Oscillator 44.12 88.65

Price Performance

Historical Comparison
TLYS
RLYB

About TLYS Tilly's Inc.

Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.

Share on Social Networks: